Colin Clancy | Senior Director of Investor Relations |
Eric Adams | President and Chief Executive Officer |
Bruce Colwill | Chief Financial Officer |
Eric Hsu | Senior Vice President, Preclinical Research and Development |
Alexandra Mancini | Senior Vice President, Clinical and Regulatory Affairs |
Shane Johnson | Senior Vice President and General Manager of BayMedica |
Mitchell Kapoor | HC Wainwright |
Scott Henry | ROTH Capital Partners |
Ken Mestemacher | Edison Group |
Good morning. My name is Shannon, and I will be your conference operator today. At this time, I would like to welcome everyone to InMed's Second Quarter Fiscal 2022 Financial Results and Business Update Conference Call for the period ended December 31, 2021. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session.